Expression of leptin in stage Ⅱ colorectal cancer and its clinical significance
10.3760/cma.j.issn.1006-9801.2017.04.004
- VernacularTitle:瘦素在Ⅱ期结直肠癌中的表达及其临床意义
- Author:
Xu CHEN
;
Yongqing ZHOU
;
Haibin DING
;
Lei NIE
;
Jing CHEN
- Keywords:
Colorectal neoplasms;
Leptin;
Prognosis;
Treatment outcome
- From:
Cancer Research and Clinic
2017;29(4):231-234
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the relationship between expression of leptin and clinical pathogenesis and prognosis of stage Ⅱ colorectal cancer.Methods The clinical data of 102 patients with colorectal cancer admitted to Shaanxi Provincial Tumor Hospital between January 2005 and December 2010 was collected and statistically analyzed.The expression of leptin in postoperative colorectal cancer tissues and 40 normal colorectal tissues was detected by P-V immunohistochemical technique.Results The expression of leptin in cancer tissues were obviously higher than that in normal tissues [59.8 ％ (61/102) vs.17.5 ％ (7/40),x 2 =20.605,P =0.000].There was no association between leptin expression level and gender,age,tumor location,pathological grading,pathological types,tumor size,invasion depth and body mass index (all P ＜ 0.05).Cox multivariate regression analysis showed that leptin expression (P =0.041) and adjuvant chemotherapy (P =0.008) were independent factors affecting OS in patients with stage Ⅱ colorectal cancer.The patients with positive expression of leptin could not benefit from the adjuvant chemotherapy (P =0.259),and patients without leptin expression had improved survival when treated by adjuvant chemotherapy (P =0.021).Conclusion The expression of leptin in stage Ⅱ colorectal cancer tissues is obviously higher than that in normal tissues.Leptin is associated with chemotherapy resistance and therapy-independent prognosis.
